drug

IMC-002

Phase 1updated 3mo ago

by ImmuneOncia Therapeutics Inc

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying IMC-002

phase1A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapyrecruitingn=62
phase1A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomascompletedn=12

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 20m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

IMC-002

Phase 1updated 3mo ago

by ImmuneOncia Therapeutics Inc

Phase 1

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying IMC-002

phase1A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapyrecruitingn=62
phase1A Study of IMC-002 in Subjects With Metastatic or Locally Advanced Solid Tumors and Relapsed or Refractory Lymphomascompletedn=12

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 20m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

IMC-002

all catalysts(0)

Trials studying IMC-002

News(0)

Report a data issue

comments(0)

IMC-002

all catalysts(0)

Trials studying IMC-002

News(0)

Report a data issue

comments(0)